bio

ETLA, the Research Institute of the Finnish Economy, conducted surveys at the end of 2004 and at the beginning of 2002 on the enterprises listed in the Index
of Biotechnology Companies in the Finnish Bioindustries organization. The surveys provide data on financial accounting, R&D activities, intellectual property rights, and sales forecasts.

This paper discusses on the policy implications for the project on “The biotechnology industry as a part of the Finnish National Innovation System” financed by Tekes, the National Technology Agency of Finland. Tekes has strongly encouraged the formation of policy implications and strategic initiatives for the biotechnology sector of Finland.

This report is a compilation of the main Canadian statistics on biotechnology. It provides a picture of the major Canadian trends in biotechnology since 1997 in three main areas. Chapter 1 covers the federal government’s scientific and technological activities in the field of biotechnology. Chapter 2 describes the characteristics of Canadian firms that are innovating in this field. Chapter 3 makes comparisons between Canada and other countries of the OECD.

Using field level data collected in Nigeria in 2003-2004, this paper examines the possibilities for learning through inter-organizational interactions in the countrys biotechnological system of innovation, using public research institutes as an example.

This report is not intended to provide an overview of national or global trends in Life Sciences or provide a detailed analysis or explanation of genetics or proteomics. Instead, it focuses on the low-hanging fruit of what is already here in the region, assets and resources to support continued growth, and some recommendations for next steps.

Researchers benchmark and assess the current position of the Greater Philadelphia life sciences sector relative to 10 other leading centers. The study includes detailed statistics from the dozens of measurements examined by researchers in each of the 11 clusters.

The report, which outlines a strategy for leveraging current assets and developing new opportunities, notes that Kentucky is considered to be an emerging novice state in the life sciences area, particularly in commercialization of research. The report also recommends 11 action steps across four areas for Kentucky to successfully compete and excel in the life sciences industry: research, commercialization capital, business talent and infrastructure.

The purpose of this paper is twofold. First, an inventory is made of biotechnology data collection in India. A second objective of this document is to present a broad overview of the status of biotechnology in India, with a focus on the agricultural and the health sector.

This Framework is intended to provide the basis for statistical compilation work within OECD member countries and those non-member countries wishing to adopt the standards. The focus is on biotechnology R&D and the application of biotechnology techniques to produce goods or services.

The report provides provides policymakers with an in-depth review of the California environment that nurtured the industry. The authors examine the role of venture capital in the formation of new firms, the founders of these firms, and the flow of existing firms into and out of the state.